Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
23 June 2015Website:
http://www.qualigeninc.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:59:33 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Qualigen Therapeutics?
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
What sector is Qualigen Therapeutics in?
Qualigen Therapeutics is in the Healthcare sector
What industry is Qualigen Therapeutics in?
Qualigen Therapeutics is in the Biotechnology industry
What country is Qualigen Therapeutics from?
Qualigen Therapeutics is headquartered in United States
When did Qualigen Therapeutics go public?
Qualigen Therapeutics initial public offering (IPO) was on 23 June 2015
What is Qualigen Therapeutics website?
https://www.qualigeninc.com
Is Qualigen Therapeutics in the S&P 500?
No, Qualigen Therapeutics is not included in the S&P 500 index
Is Qualigen Therapeutics in the NASDAQ 100?
No, Qualigen Therapeutics is not included in the NASDAQ 100 index
Is Qualigen Therapeutics in the Dow Jones?
No, Qualigen Therapeutics is not included in the Dow Jones index
When does Qualigen Therapeutics report earnings?
The next expected earnings date for Qualigen Therapeutics is 14 August 2024